CVE-2012-0272
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0...
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0 before Support Pack 3 allows remote attackers to inject arbitrary web script or HTML via the merge parameter.
Exploit likelihood
What each source reports
NVD Score used
4.3
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0 before Support Pack 3 allows remote attackers to inject arbitrary web script or HTML via the merge parameter.
- Record
CVE-2012-0272- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0 before Support Pack 3 allows remote attackers to inject arbitrary web script or HTML via the merge parameter.
- Record
CVE-2012-0272- Updated
- 2026-11-02
EUVDEUVD-2012-0308 No score
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0 before Support Pack 3 allows remote attackers to inject arbitrary web script or HTML via the merge parameter.
- Record
EUVD-2012-0308- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vmw7-x5rv-p67w No score
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0...
Cross-site scripting (XSS) vulnerability in the WebAccess component in Novell GroupWise 8.0 before Support Pack 3 allows remote attackers to inject arbitrary web script or HTML via the merge parameter.
- Record
GHSA-vmw7-x5rv-p67w- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2012-0272 is a medium vulnerability (CVSS 4.3) in Novell Groupwise, published September 19, 2012. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.30%, the 70th percentile. No source names a fixed version.